Novo Reports CagriSema Weight Loss and Function Results
Plainsboro, New Jersey, USA, and Bagsværd, Denmark, November 15, 2026 Novo Nordisk has announced two new post hoc analyses...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
Plainsboro, New Jersey, USA, and Bagsværd, Denmark, November 15, 2026 Novo Nordisk has announced two new post hoc analyses...
Indianapolis, Indiana, USA, November 14, 2026 Eli Lilly and Company has announced a comprehensive set of new clinical trial...
Washington, D.C., USA, November 14, 2026 Novo Nordisk has announced positive primary results from its Phase 3 REDEFINE 9...
Ingelheim am Rhein, Germany, November 9, 2026 Boehringer Ingelheim has announced positive results from its global Phase III SYNCHRONIZE-CVOT...
Plainsboro, New Jersey, USA, and Bagsværd, Denmark, November 6, 2026 Novo Nordisk has announced new real-world clinical findings showing...
Hong Kong, China, October 29, 2026 Ascletis Pharma Inc. has announced positive topline results from its U.S. Phase 2...
CAMBRIDGE, Mass. — September 23, 2026 Wave Life Sciences announced the initiation of a Phase 2a clinical trial evaluating...
SOLANA BEACH, Calif. — September 23, 2026 Artelo Biosciences announced that it has filed a new provisional patent application...
San Diego, California, U.S., September 22, 2026 Viking Therapeutics, Inc. has announced positive topline results from a maintenance study...
HARWELL, Oxford, UK — September 17, 2026 MitoRx Therapeutics announced that new data for its lead mitochondrial-targeted small molecule...
